📢 @ohenews.bsky.social at the CEPR - Centre for Economic Policy Research Conference on the Economics of Longevity and Ageing. We are pleased to share that @Mireia Jofre-Bonet has been invited to participate in a panel discussion on the economic impacts of dementia.

A great day at Dementia Day 2026 – Building Bridges Together at Alzheimercentrum @erasmusmc.bsky.social! Congratulations to our partner Laura Dias, who received the poster prize for her work on "Modeling of White Matter Degeneration in Genetic Frontotemporal Dementia." 🏆

Our project partner, Alzheimer Europe, has just published the newest edition of Dementia in Europe magazine! Explore the latest stories and insights on dementia research, policy, care, and lived experience from across Europe.

Congratulations to Kuopio Neuroscience on its 50th anniversary! 🎉 Great to see PREDICTFTD partners taking part in the FinFTD Minisymposium in Kuopio, Finland, discussing FTD biomarkers, epidemiology, clinical phenotypes, and the importance of international collaboration.

📃 We’re excited to share our new PREDICTFTD flyer highlighting the potential of nasal (olfactory) swabs in frontotemporal dementia research. www.predictftd.eu/disseminatio...

Prof. Harro Seelaar (@erasmusmc.bsky.social), PREDICTFTD Coordinator, joined the latest @alzheimereurope.bsky.social Academy session, “Not all dementias are Alzheimer’s disease,” to share a clinician’s perspective on frontotemporal dementia (FTD). www.alzheimer-europe.org/news/alzheim...

📢 On International Clinical Trials Day, we recognise the vital contribution of people who participate in clinical research and help drive progress in dementia care.

Blood-based biomarkers are rapidly transforming the future of neurodegenerative disease detection - not only for Alzheimer’s disease, but across the wider dementia landscape.

💡 As part of our partner introduction series, we’re excited to feature the Università degli Studi di Verona. ➡️ In PREDICTFTD the University of Verona contributes to early biomarker validation studies in olfactory mucosa samples using nasal swabs. 🖇️ Find more: lnkd.in/dgaFakjA

@uniuef.bsky.social University of Eastern Finland is a research university located in Finland, with strong focus in neurodegenerative diseases research. 🌟 In PREDICTFTD project, UEF leads prospective data and sample collection and contributes to providing samples, data and local expertise. 🧠

PREDICTFTD coordinator Prof. Harro Seelaar from erasmusmc.bsky.social participated in the latest Alzheimer Europe Academy session, “Not all dementias are Alzheimer’s disease”. During the workshop, Prof. Harro shared a clinician’s perspective on frontotemporal dementia (FTD).

Blood-based biomarkers are rapidly transforming the future of neurodegenerative disease detection - not only for Alzheimer’s disease, but across the wider dementia landscape.

Members of the @predictftd.bsky.social Public Involvement Board recently held two meetings with the Office of Health Economics to discuss the value of a faster and more accurate Frontotemporal dementia diagnosis. #PublicInvolvement #FrontotemporalDementia www.alzheimer-europe.org/news/members...

The PREDICTFTD project @predictftd.bsky.social recently held its general assembly meeting in Desenzano del Garda (Italy). Read all about the meeting: www.alzheimer-europe.org/news/predict...

This World Health Day, we bring attention to one of the biggest challenges in neurodegenerative diseases: late and uncertain diagnosis. 🧠 PREDICTFTD aims to transform FTD diagnosis by overcoming the current 3.6-year diagnostic delay! #WorldHealthDay #FTD #Biomarkers #EUProjects

Day 2 of the PREDICTFTD project meeting in Desenzano del Garda. 🌍 A focused day covering biomarker work, AI modelling, and an overview of the olfactory (nasal) swab sampling. We also had important discussions on the regulatory roadmap and ethics - important pieces as the project moves forward.

Day 1 of the PREDICTFTD consortium meeting in Desenzano del Garda! We kicked off with updates across the project, from ongoing work packages to a really interesting demo of how our data systems are coming together. More tomorrow.🚀 #PREDICTFTD

In light of Brain Awareness Week, we are preparing for our upcoming team meeting. 🌍 The PREDICTFTD partners will meet in person on March 26–27, 2026, in Desenzano del Garda, Italy. Looking forward to two productive days of discussion and exchange. 🧠

This Brain Awareness Week, we’re spotlighting the fight against FTD. 🧠 Our goal is vital: to give clinicians the tools they need to diagnose FTD faster, enabling earlier intervention and better care. Learn more about our approach: www.predictftd.eu

The recent @alzheimereurope.bsky.social Europe data on dementia prevalence across Europe is a strong reminder of the growing impact of neurodegenerative diseases! www.alzheimer-europe.org/dementia/pre...

During #BrainAwarenessWeek, we'd also like to share our new "Prevalence of Dementia in Europe 2025" report. The results show that policy and advocacy are more important than ever. 🧠Where does your country stand? bit.ly/DementiaPrev... bit.ly/DementiaPrev... #dementiaprevalence #dementiaineurope

People with #dementia and carers are experts in lived experience. This #BrainAwarenessWeek, we recognise that #PublicInvolvement shapes research, policy and awareness. #EWGPWD #EDCWG Learn more about: Technology use: bit.ly/4sSR5Bv Sex, Gender and Sexuality bit.ly/4s9DmpJ (DE) bit.ly/4seWClT (FR)

🔬@Leitat Technological Center, Spain, participate in the assessment of the diagnostic potential of biomarkers for FTD detection in the PREDICTFTD project. LEITAT works on biomarker analysis and validation, leading ​Biomarkers study using Luminex Technology​. ✔️ 🔗 Discover more: leitat.org

🌍Teraglobus is a Lithuanian SME engaged in dissemination, exploitation, stakeholder involvement, and healthcare consulting within EU-funded projects. 🔗 Discover more: www.teraglobus.lt

📣 Our first PREDICTFTD newsletter is out! 👉https://www.predictftd.eu/newsletters Open the link to read the newsletter and learn more about what we’re working on.

As part of our partner introduction series, we’re excited to feature Alzheimer Europe. 🤝 In the PREDICTFTD project, @alzheimereurope.bsky.social plays a central role in involving people affected by FTD, raising awareness, engaging stakeholders, and building a dialogue with EU policymakers.

For PREDICTFTD, our partner @dzne.science offers extensive FTD patient data, including MRI, neuropsychology, and genetics. DZNE supports retrospective data collection and delivers patient samples for biomarker analysis and evaluation. 🔗 Learn more: www.dzne.en

🧠 On Nov 7, the PREDICTFTD consortium meets online for its Plenary Session, a key moment to review progress, strengthen coordination, and plan next steps toward advancing early, accurate diagnosis of frontotemporal dementia. #PREDICTFTD #DementiaResearch

🧠 The PREDICTFTD leaflet is now online! Discover how the project advances early and accurate diagnosis of familial and sporadic frontotemporal dementia (FTD) through predictive liquid biomarkers and AI-assisted diagnostic tools. Find the leaflet and share👉 www.predictftd.eu

The PREDICTFTD project will participate in the 35th Alzheimer Europe Conference (6–8 October 2025, Bologna). Looking forward to connecting with colleagues, sharing insights & exploring the future of dementia care. ▶️Find out more: www.alzheimer-europe.org/conferences/...

Frontotemporal dementia carries a major economic & societal burden, worsened by delayed diagnosis. Within PREDICT-FTD, OHE explores costs, caregiver impact & the case for biomarker-based diagnosis. Read more: www.ohe.org/insights/the...

For many families, FTD starts with confusion and delayed answers. 💜 This #FTDAwarenessWeek, we call for earlier recognition and better support. In PREDICTFTD, with Alzheimer Europe, lived experience guides efforts to improve diagnosis and quality of life.

It’s FTD Awareness Week Hearing from those living with FTD shows resilience & determination beyond diagnosis. In PREDICTFTD, board member Margaret works with Alzheimer Europe to ensure that lived experience guides research and improves outcomes for patients and caregivers.

This week is #FTDAwarenessWeek FTD often goes unnoticed & misunderstood, yet behind every diagnosis is resilience, struggle & love. Real experiences are vital for PREDICTFTD. Stephen, dementia advocate & board member, joins Alzheimer Europe to bring his experience to the center of awareness & change

🚀 Continuing our Partner Introduction Series: @idibaps.bsky.social 🧠 The Alzheimer’s and cognitive disorders unit specializes in early and preclinical neurodegenerative dementias. They bring valuable samples and data from previous FTD cohorts and will recruit patients for PREDICTFTD as well.

🚀We begin our partner introduction series with @erasmusmc.bsky.social, which hosts the Biomedical Imaging Group Rotterdam (BIGR) — a team of 40 brilliant AI and imaging researchers. They coordinate and oversee data infrastructure, data collection, project management, and AI model development.

In the near future, a person could walk into a clinic, provide a blood sample, and—within weeks—receive an accurate, AI-assisted diagnosis that not only detects Frontotemporal Dementia (FTD) at an early stage but also identifies its molecular subtype. This is the vision of PREDICTFTD.

🚀 The PREDICTFTD Website Is Now Live! 🧠 Explore how we're working together to enable earlier and more accurate diagnosis of FTD—paving the way for tailored care and treatment. 📍 Visit us at: www.predictftd.eu PREDICTFTD is funded by the European Union under the Grant Agreement n° 01156175.

🔬 Our Mission in PREDICTFTD We are proud to be developing a cutting-edge diagnostic tool for the early detection of Frontotemporal Dementia (FTD) — enabling tailored care and support. Through the integration of: ✔️ Liquid biomarkers ✔️ AI-powered diagnostic algorithms ✔️ Multimodal clinical data

🧠 Why PREDICTFTD? Frontotemporal dementia (FTD) has a debilitating effect on patients, caregivers, and healthcare systems. 🔍 While 15–30% of cases are genetic, the majority — 70–85% — are sporadic, often leading to frequent misdiagnosis and an average delay of over 3.5 years before diagnosis.

💡 Members of the PREDICTFTD Public Involvement Board gather online for the first time to discuss different aspects of a Frontotemporal dementia diagnosis. This consultation was attended and facilitated by Soraya Moradi Bachiller, Public Involvement Officer at Alzheimer Europe.

We are thrilled to share the wrap-up of the PREDICTFTD project Kick-off Meeting! @erasmusmc.bsky.social @leitat.bsky.social @dzne.science @unihalle.bsky.social @idibaps.bsky.social @ohenews.bsky.social www.youtube.com/watch?v=hwhH...

🚀 Our partners at the University of Eastern Finland have shared an update on the launch of PREDICTFTD project! 📖 You can read the article in Finnish on the link below. www.uef.fi/fi/artikkeli...

We’re excited to share that the PREDICTFTD project start has been announced in an article by our partner Erasmus MC! 🎉 Read more: amazingerasmusmc.com/neurology/wa... PREDICTFTD is funded by the European Union under the Grant Agreement n° 01156175.